Restoring the Dysfunctional Endothelium

Author(s): Elena Osto, Giuseppe Coppolino, Massimo Volpe, Francesco Cosentino

Journal Name: Current Pharmaceutical Design

Volume 13 , Issue 10 , 2007

Become EABM
Become Reviewer
Call for Editor


Nowdays the endothelium is considered a key determinant of vascular health. NO is the principal mediator of all endothelial protective effects, due to its antinflammatory, antiproliferative, immunomodulatory and vasorelaxant properties. On the contrary, a growing body of evidence suggests that endothelial dysfunction is associated with cardiovascular events. Emerging data suggest that acute coronary syndromes (ACS) may involve a complex interplay between endothelial dysfunction, inflammation and thrombosis. Despite the success in reducing the mortality from acute cardiovascular events, the incidence of cardiovascular disease and its complication continues to increase. New insights into mechanisms of endothelial dysfunction, such as a better understanding of the regulation of vascular sources of oxygen radicals, may lead to novel therapeutic strategies with the potential to improve prognosis. The key pharmacological agents that improve clinical outcome in high-risk patients are statins, ACE-inhibitors or angiotensin receptor antagonists. Compelling scientific evidence suggests that these medications are effective in improving endothelial function. The present review focuses on the potential importance of benefits on endothelium of these medicaments in the management of acute coronary syndromes.

Keywords: Nitric oxide, endothelial dysfunction, atherosclerosis, coronary artery disease, statin, ACEI, ARB, review

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [1053 - 1068]
Pages: 16
DOI: 10.2174/138161207780487566
Price: $65

Article Metrics

PDF: 6